HOLLY MCDOUGALL: Open Payments
NPI 1558942508 · BINGHAM FARMS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$514 in 14 payments from 12 companies in 2025. Trend: 2023 $323 · 2024 $530 · 2025 $514
Food & beverage: $260Education: $254
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 2 | $116 |
| SANOFI-AVENTIS U.S. LLC | 1 | $93 |
| AstraZeneca Pharmaceuticals LP | 1 | $68 |
| Merck Sharp & Dohme LLC | 2 | $54 |
| Blueprint Medicines Corporation | 1 | $30 |
| SOBI, INC | 1 | $29 |
| Exelixis Inc. | 1 | $24 |
| Azurity Pharmaceuticals, Inc. | 1 | $22 |
| CSL Behring | 1 | $21 |
| Genentech USA, Inc. | 1 | $20 |
Products named: SARCLISA, IMFINZI, KEYTRUDA, AYVAKIT, Doptelet, CABOMETYX, JAKAFI, DANZITEN.
Industry payments across MI — which companies pay providers there.
